Brief: Modus Therapeutics Resolves On Compensation Issue
03/09/2025 08:05
Sept 3 (Reuters) - Modus Therapeutics Holding AB MODTX.ST: SAID ON TUESDAY RESOLVES ON COMPENSATION ISSUE TO GUARANTORS IN COMPLETED RIGHTS ISSUE SUBSCRIPTION PRICE IN THE COMPENSATION ISSUE AMOUNTS TO SEK 3.15 PER UNIT, CORRESPONDING TO SEK 0.35 PER SHARE PAYMENT WILL BE MADE BY SET-OFF OF THE GUARANTORS’ CLAIMS Further company coverage: MODTX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Modus Therapeutics Holding AB
See all newsBrief: Modus Therapeutics Temporarily Pauses Enrollment In Phase IIa Study Of Sevuparin In CKD With Anemia
Brief: Modus Gets SEK 0.13 Mln Through Exercise Of Warrants
Brief: Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares
Sweden's Modus Therapeutics narrows Q2 net loss, extends financing
Brief: Modus Therapeutics Q2 Net Income SEK -4.645 Million